| Literature DB >> 36203980 |
Ruili Li1,2,3, Yuxun Gao2, Wei Wang2, Zengxin Jiao2, Bo Rao4, Guangxue Liu5, Hongjun Li2.
Abstract
Background: While regional brain structure and function alterations in HIV-infected individuals have been reported, knowledge about the topological organization in gray matter networks is limited. This research aims to investigate the effects of early HIV infection and combination antiretroviral therapy (cART) on gray matter structural covariance networks (SCNs) by employing graph theoretical analysis.Entities:
Keywords: 3D-T1WI; HIV; cognitive function; combination antiretroviral therapy; structural covariance network
Year: 2022 PMID: 36203980 PMCID: PMC9530039 DOI: 10.3389/fneur.2022.869871
Source DB: PubMed Journal: Front Neurol ISSN: 1664-2295 Impact factor: 4.086
Cognitive domains and corresponding neurocognitive scales.
|
|
|
|---|---|
| Verbal fluency | Animal verbal fluency test (AFT) |
| Executive function | Wisconsin card sorting tests (WCST-64) |
| Speed of information processing | Trail marking test A (TMT-A) |
| Fine motor skills | Grooved pegboard |
| Attention/working memory | ①Continuous performance test-identical pair (CPT-IP) |
| Learning and delayed recall | ①Hopking verbal learning test (HVLT-R) |
Demographic, clinical variables, and neuropsychological data.
|
|
|
|
| |
|---|---|---|---|---|
| Sex (M/F) | 32/2 | 29/2 | 33/2 | 1.000 |
| Age (years), median (IQR) | 29.5(25.75–36) | 30(27–33) | 33 (29–36) | 0.273 |
| Education level (years), median (IQR) | 16(16–16.5) | 16(16–16) | 16(16–18) | 0.825 |
| Time since HIV diagnosis (months), median (IQR) | 29.5(21–49.25) | 4(3–11) | / | 0.000[ |
| Time of infection without cART, (months), median (IQR) | 2(1–9) | 4(3–11) | / | 0.108 |
| Time on cART (months), median (IQR) | 23.5(18–48) | / | / | / |
| CD4+ (cells/μl), median (IQR) | 515(412.39–651.93) | 431.85(346–570) | / | 0.121 |
| CD4+/CD8+ ratio, median (IQR) | 0.63(0.45–0.88) | 0.45(0.33–0.54) | / | 0.002[ |
| Plasma viral load (IQR) | TND | 4320(50–26533) | / | / |
| Scores of cognitive performance | ||||
| Verbal fluency (mean SD) | 44.9 ± 8.9 | 46.1 ± 7.5 | / | 0.544 |
| Attention/working memory, median (mean±SD) | 40.9 ± 6.6 | 41.6 ± 6.1 | / | 0.648 |
| Executive function, median (mean±SD) | 55.7 ± 11.0 | 55.0 ± 7.8 | / | 0.783 |
| Memory (learning/delayed recall) (mean±SD) | 42.9 ± 8.6 | 43.3 ± 8.0 | / | 0.841 |
| Speed of information processing (mean±SD) | 45.0 ± 9.5 | 47.7 ± 9.4 | / | 0.257 |
| Fine motor (mean±SD) | 43.2 ± 9.4 | 47.3 ± 7.8 | / | 0.061 |
| Cognitive status (ANI/non–HAND) | 16/18 | 10/21 | / | 0.311 |
HIV+/cART+, HIV individuals receiving stable cART; HIV+/cART–, therapy-naïve HIV individuals; HCs, healthy controls; M, male; F, female; IQR, interquartile range; TND, undetectable; ANI, asymptomatic neurocognitive impairment; HAND, HIV-associated neurocognitive disorders;
χ2 test;
Kruskal–Wallis test;
Mann–Whitney U-test;
independent sample Student's t-test;
significant level p < 0.05; /, no data available.
Mathematical definitions, interpretation, and clinical significance of the network metrics (44).
|
|
|
|---|---|
|
| |
| Degree of a node i ( | |
| Number of triangles around a node i ( | |
| The mean nodal path length (Nlp) of node i ( | |
| Betweenness centrality (Bc) of node | |
| Modularity of the network ( | |
| Global efficiency of the network ( | |
| Local efficiency of the network ( | |
| Clustering coefficient of the network ( | |
| Characteristic path length of the network ( | |
| Small-worldness (σ) = γ / λ. ( |
Post-hoc analyses results of the altered network metrics among the three groups.
|
| ||||||
|---|---|---|---|---|---|---|
|
|
|
|
|
|
| |
|
| ||||||
|
| ||||||
| SFG.L | −3.94857 | 0.00019 | −4.23647 | 0.00008 | NS | NS |
| SFG.R | −3.85112 | 0.00027 | NS | NS | −4.27178 | 0.00007 |
|
| ||||||
| ITG.L | −4.75678 | 0.00001 | NS | NS | NS | NS |
| LING.L | −5.54638 | 0.00000 | −4.90126 | 0.00000 | NS | NS |
| LING.R | NS | NS | NS | NS | −4.08712 | 0.00013 |
| PCL.L | −7.15180 | 0.00000 | −7.68687 | 0.00000 | NS | NS |
| CAL.L | NS | NS | NS | NS | 4.10505 | 0.00012 |
| CAL.R | −5.33397 | 0.00000 | NS | NS | −6.50684 | 0.00000 |
| PoCG.L | −4.11746 | 0.00011 | −4.61510 | 0.00002 | NS | NS |
| PoCG.R | NS | NS | NS | NS | −4.21494 | 0.00008 |
| PCUN.L | 5.66704 | 0.00000 | NS | NS | NS | NS |
| SPG.R | −8.27225 | 0.00000 | NS | NS | −5.50156 | 0.00000 |
| ACG.L | NS | NS | 6.05058 | 0.00000 | −7.09450 | 0.00000 |
|
| ||||||
|
| ||||||
| 0.20 | 2.49 | 0.01530 | NS | NS | 3.74 | 0.00041 |
| 0.25 | NS | NS | NS | NS | 4.15 | 0.00011 |
|
| ||||||
| Q0.05 | −3.83 | 0.00028 | NS | NS | −3.79 | 0.00034 |
| Q0.10 | −3.86 | 0.00026 | NS | NS | −5.53 | 0.00000 |
| Q0.15 | −3.91 | 0.00022 | NS | NS | −5.53 | 0.00000 |
| Q0.20 | −4.14 | 0.00010 | NS | NS | −5.79 | 0.00000 |
| Q0.25 | −5.03 | 0.00000 | NS | NS | −6.22 | 0.00000 |
| Q0.30 | −4.94 | 0.00000 | NS | NS | −5.67 | 0.00000 |
| Q0.35 | −5.18 | 0.00000 | NS | NS | −5.46 | 0.00000 |
| Q0.40 | −5.61 | 0.00000 | NS | NS | −5.85 | 0.00000 |
| Q0.45 | −5.33 | 0.00000 | NS | NS | −6.07 | 0.00000 |
| Q0.50 | −5.95 | 0.00000 | NS | NS | −6.61 | 0.00000 |
|
| ||||||
| Eglob | 6.55 | 0.00000 | 3.54 | 0.00075 | 3.99 | 0.00018 |
| Eloc | 5.34 | 0.00000 | 3.60 | 0.00063 | 2.47 | 0.01620 |
|
| ||||||
| Gamma, γ | −4.48 | 0.00003 | NS | NS | −4.13 | 0.00011 |
| Lambda, λ | NS | NS | 4.07 | 0.00013 | −4.85 | 0.00000 |
| Sigma, σ | −4.03 | 0.00014 | NS | NS | −3.14 | 0.00259 |
HIV+/cART+, HIV individuals receiving stable cART; HIV+/cART–, therapy-naïve HIV individuals; HCs, healthy controls; Nlp, the average of the shortest-path length from a node to any other node in the network; SFG, superior frontal gyrus; L, left; R, right; NS, not significant; Bc, Betweenness centrality; ITG, inferior temporal gyrus; LING, lingual gyrus; PCL, paracentral lobule; CAL, pericalcarine cortex; PoCG, postcentral gyrus; PCUN, precuneus; SPG, superior parietal gyrus; ACG, anterior cingulate gyri; Mod_num, number of modules; Q, modularity; Eglob, global efficiency; Eloc, local efficiency; γ, normalized clustering coefficient; λ, normalized characteristic path length; σ, small-worldness. t-value, a positive value represents the network metric value of the former group, which is higher than the latter, and a negative value represents a decrease.
Figure 1Between-group results in regional nodal metrics-Nlp. The color bar scales represent the t value of Nlp difference between groups, a positive t value represents the Nlp of the former group is higher than the latter, and a negative value represents a decrease (presented in blue). (A) HIV+/cART+ < HCs. (B) HIV+/cART– < HCs. (C) HIV+/cART+ < HIV+/cART–. Nlp, the average of the shortest-path length from a node to any other node in the network; HCs, healthy controls; SFG, superior frontal gyrus; L, left; R, right.
Figure 2Between-group results in regional nodal metrics-Bc. The color bar scales represent the t value of Bc difference between groups. Blue (a negative t value) indicates that the former < the latter. Red and yellow (a positive t value) indicate that the former > the latter. Compared with HCs, Bc in the parietal lobe and occipital lobe decreased both in HIV+/cART+ (A) and HIV+/cART– group (B), and the brain area of decreased Bc in HIV+/cART+ group was more extensive (C). L, left; R, right; ITG, inferior temporal gyrus; LING, lingual gyrus; PCL, paracentral lobule; CAL, pericalcarine cortex; PoCG, postcentral gyrus; PCUN, precuneus; SPG, superior parietal gyrus; ACG, anterior cingulate gyri.
Figure 3Between-group results in network community metrics number of modules (A, B) and modularity index Q (C, D). At the threshold of 0.20, the number of modules in HIV+/cART+ was more than that in HCs (at the threshold of 0.20) and HIV+/cART– (at the threshold of 0.20 and 0.25). However, the modularity index Q of the HIV+/cART+ was significantly lower than that of the HCs and HIV+/cART– within the entire threshold range (0.05–0.50).
Figure 4Between-group results in large-scale metrics (A, B) and small-world properties (C–E). The asterisks designate significant differences between the two groups. AUC, area under the curve; Eglob, global efficiency; Eloc, local efficiency; HCs, healthy controls; γ, normalized clustering coefficient; λ, normalized characteristic path length; σ, small-worldness; *p value < 0.05.
Figure 5All three groups exhibited the typical features of small-worldness (A) γ > 1, (B) λ ≈ 1, and (C) σ > 1. γ, normalized clustering coefficient; λ, normalized characteristic path length; σ, small-worldness.